Genedata has released Genedata Biologics 1.5, the latest version of its enterprise solution for biologics R&D.
The new package provides support for cross-departmental and external data exchange as well as technology transfers among research partners, such as pharmaceutical and biotech companies, technology providers, contract research organisations (CROs), and academic research networks. Genedata Biologics was specifically designed to support Open Innovation models.
Genedata Biologics is a first-in-class, off-the-shelf software solution for integrated data management and analysis of biologics R&D activities. It streamlines and automates the biologics lead generation and optimisation process, including antibody screening, protein engineering, and protein production. These capabilities enable pharmaceutical and biotechnology R&D organisations to more efficiently discover and develop novel protein-based therapies.